companydata.dkACESION PHARMA ApS: Financial statements 2015
CVR: 34083738
ACESION PHARMA ApS (CVR 34083738) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK -8,496,428 and a net result of DKK -9,804,270 compared with DKK -6,455,117 the year before. Equity amounted to DKK 1,535,501. The solvency ratio was 8.9%.
- Gross Profit
- -8,496,428 kr.
- Profit/Loss
- -9,804,270 kr.
- Equity
- 1,535,501 kr.
- Total Assets
- 17,287,972 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | -8.5 mio. | -9.8 mio. | 1.5 mio. | - |
| 2014 | - | -4.7 mio. | -6.5 mio. | 3.8 mio. | - |
| 2013 | - | -4.8 mio. | -6.5 mio. | -556 t. | - |
| 2012 | - | -1.3 mio. | -2.1 mio. | 2 mio. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2015
As of August 15, 2015, Stephan Christgau has joined the board of directors of ACESION PHARMA ApS.
As of August 15, 2015, Bobby G Soni has left the board of directors of ACESION PHARMA ApS.
ACESION PHARMA ApS has published its annual report for 2014. Gross profit came to DKK -4,722,342, and the net result was DKK -6,455,117.
About ACESION PHARMA ApS
ACESION PHARMA ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Anders Gaarsdal Holst. The company's owners include Novo Holdings A/S, Canaan XII L.P. and Alpha Wave Ventures II, LP. The company has 14 employees. In 2025, the company reported a net result of DKK -59,597,000 compared with DKK -43,033,000 the year before. Equity amounted to DKK 276,067,000.